FDA Import Refusal AEK-9414514-9/30003/1 — NEOLPHARMA S.A.
The FDA refused shipment AEK-9414514-9/30003/1 from NEOLPHARMA S.A. (Mexico) on Mar 6, 2026. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charges: 118,75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Mar 6, 2026
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 62GCY49 NAPROXEN (ANTI-INFLAMMATORY)
- Charges
- 118,75